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Abstract
The stress-inducible small heat shock protein (shsp)/aB-crystallin gene is expressed highly in the lens and moderately in other
tissues. Here we provide evidence that it is a target gene of the aryl hydrocarbon receptor (AhR) transcription factor. A
sequence (2329/2323, CATGCGA) similar to the consensus xenobiotic responsive element (XRE), called here XRE-like, is
present in the aBE2 region of aB-crystallin enhancer and can bind AhR in vitro and in vivo. aB-crystallin protein levels were
reduced in retina, lens, cornea, heart, skeletal muscle and cultured muscle fibroblasts of AhR
2/2 mice; aB-crystallin mRNA
levels were reduced in the eye, heart and skeletal muscle of AhR
2/2 mice. Increased AhR stimulated aB-crystallin expression
in transfection experiments conducted in conjunction with the aryl hydrocarbon receptor nuclear translocator (ARNT) and
decreased AhR reduced aB-crystallin expression. AhR effect on aB-crystallin promoter activity was cell-dependent in
transfection experiments. AhR up-regulated aB-crystallin promoter activity in transfected HeLa, NIH3T3 and COS-7 cells in
the absence of exogenously added ligand (TCDD), but had no effect on the aB-crystallin promoter in C2C12, CV-1 or Hepa-1
cells with or without TCDD. TCDD enhanced AhR-stimulated aB-crystallin promoter activity in transfected aTN4 cells. AhR
could bind to an XRE-like site in the aB-crystallin enhancer in vitro and in vivo. Finally, site-specific mutagenesis experiments
showed that the XRE-like motif was necessary for both basal and maximal AhR-induction of aB-crystallin promoter activity.
Our data strongly suggest that AhR is a regulator of aB-crystallin gene expression and provide new avenues of research for
the mechanism of tissue-specific aB-crystallin gene regulation under normal and physiologically stressed conditions.
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Introduction
The aB-crystallin and HspB2 genes, both members of the small
heat shock protein gene family, are arranged head-to-head with an
approximate 1 kb intergenic region in the human, mouse and rat
genomes [1]. In the mouse, the intergenic sequence contains an
orientation-dependent enhancer that differentially directs expres-
sion of the aB-crystallin gene to different tissues, with the highest
expressions being in the eye lens, heart and skeletal muscle [2,3].
Although little is known about regulation of HspB2 gene expression,
aB-crystallin gene expression has been well studied. Specific
transcription factors are known that regulate the proximal promoter
and each of the enhancer cis-elements, except for the aBE2
enhancer element, of the aB-crystallin gene [4,5,6,7,8,9] (Fig. 1).
In the present investigation we scanned the HspB2/aB-crystallin
intergenic regulatory region and identified a candidate aryl
hydrocarbon receptor(AhR) binding site, CATGCGA, at the edge
of aBE2 (Fig. 1). The DNA binding site for AhR is called the
xenobiotic responsive element (XRE) or dioxin response element
(DRE) [10,11]. The core consensus sequence for a functional XRE
present in enhancers of known AhR-regulated genes (i.e. cyp1a1,
cyp1a2, cyp1b1) is CACGCNA. Recently another AhR recognizing
sequence, XRE-II, was recognized in the enhancer of cyp1a2 [12];
XRE-II binds the AhR/aryl hydrocarbon receptor nuclear
translocator (ARNT) with the mediation of an unknown protein.
The core sequence of XRE-II is identified as CATG{N6}C[T/
A]TG [12,13]. Since the potential AhR binding site in the aBE2 of
aB-crystallin is not a perfect match with either XRE-I or XRE-II,
we term this site the XRE-like motif.
AhR belongs to the bHLH /PAS (basic Helix-Loop-Helix/Per
Arnt Sim) transcription factor family. Members of this family play
critical roles in a broad range of biological functions including
regulation of circadian rhythm, neurogenesis, hypoxia response
and drug metabolism. A well-established mechanism for AhR
function of detoxification starts from its activation by a ligand,
usually a dioxin, followed by transport to the cell nucleus, where
the AhR forms a heterodimer with ARNT. The AhR/ARNT
complex binds to XRE motifs in the regulatory regions of its target
genes. Most AhR-regulated genes (cyp1a1, cyp 1a2, cyp 1b1,
glutathione-S-transferase Ya and NAD(P)H-quinone oxidoreductase) me-
tabolize xenobiotics [14,15,16]. While the detoxification role of
AhR has been well investigated, very little is known about the
other functions of this ancient protein. Recent studies on AhR null
mice have revealed de novo physiologic functions of AhR in
addition to induction of detoxification genes, and many new
potential AhR regulated genes have been identified by high-
throughput technologies [13,17,18]. The present study provides
evidence that AhR regulates small heat shock protein/aB-crystallin gene
expression in a ligand-independent fashion.
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aB-Crystallin is Decreased in AhR Null Mice
We examined aB-crystallin expression levels in different tissues of
adult AhR
2/2 and AhR
+/+ mice [19]. aB-crystallin protein levels in
the retina, lens, cornea, heart and skeletal muscles were reduced in
AhR
2/2 mice compared to AhR
+/+ mice (Fig. 2A).
The retina, lens, cornea, heart and skeletal muscle contain
either abundant (lens, heart, skeletal muscle) or moderate
(cornea, retina) levels of aB-crystallin [20,21,22,23]. aB-crystallin
was undetectable in the retina and reduced by approximately 3-
fold in the cornea, heart and skeletal muscle, and 2-fold in the
lens of AhR
2/2 mice. b-actin was at comparable levels in these
tissues in the AhR
2/2 and AhR
+/+ mice. aB-crystallin mRNA
levels were reduced approximately 7-fold in the eyes (whole
eyeball), 3-fold in the heart and 2-fold in skeletal muscle of the
AhR
2/2 mice compared to the age-matched AhR
+/+ mice
(Fig. 2B).
We also compared the levels of aB-crystallin in primary cultures
of muscle derived fibroblast cells from AhR
2/2 and AhR
+/+ mice
(Fig. 2A). There was much less ( 0.3-fold) aB-crystallin in AhR
2/2
fibroblasts compared to AhR
+/+ fibroblasts. The absence of AhR
in the primary AhR
2/2 fibroblast cells was confirmed by
immunoblotting (data not shown).
We next tested whether reducing AhR levels by siRNA or
increasing AhR levels using plasmids encoding AhR and ARNT
would affect aB-crystallin levels in cultured rabbit lens aTN4
cells. AhR siRNA reduced AhR level by 65% and aB-crystallin
level by 78%, respectively (Fig. 3A). By contrast, overexpression
of AhR/ARNT increased aB-crystallin expression in a dose
dependent manner (Fig. 3B). Together, these results are
consistent with AhR being a positive regulator of aB-crystallin
gene expression.
AhR/ARNT Upregulates aB-crystallin Promoter Activity
Independently of Exogenous Ligand
We next examined whether AhR can regulate aB-crystallin
promoter activity. We used a duel reporter plasmid,
pFLHspB2aBRL [3], which contains the 1 kb intergenic
regulatory region between the head-to-head aB-crystallin and
HspB2 genes. In this plasmid the proximal promoter of HspB2
drives the firefly luciferase gene and the proximal promoter of
aB-crystallin drives the Renilla luciferase gene (Fig. 4A), thus
allowing us to detect the effect of transcription factors on each of
the promoters simultaneously. HeLa cells were transfected with
the plasmids encoding mouse AhR and ARNT and the Renilla
and firefly luciferase activities were determined. As shown in
Fig. 4B, AhR/ARNT had no significant effect on HspB2
promoter activity, but increased aB-crystallin promoter activity
by 9.1-fold. In order to identify individual contributions of AhR
and ARNT, we tested their dose effects individually on aB-
crystallin promoter activity. AhR and ARNT each up-regulated
aB-crystallin promoter activity in a dose-dependent fashion; the
combination of AhR and ARNT had an additive positive effect
on the activity of the aB-crystallin promoter (Fig. 5A). By contrast,
AhR/ARNT had little, if any, effect on HspB2 promoter activity
(data not shown).
Unexpectedly, our data indicated that AhR does not require an
exogenous ligand to stimulate aB-crystallin promoter activity. Thus,
we further tested the effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin
(TCDD), the prototypical ligand of AhR [15,16,24], on the ability
of AhR to stimulate aB-crystallin promoter activity. Fig. 5B shows
that TCDD did not augment the stimulation of aB-crystallin
promoter activity by AhR/ARNT. In additional tests, a high
ligand-affinity AhR (C57BL/6AhR) and a low ligand-affinity AhR
(DBA/2AhR) [25] up-regulated aB-crystallin promoter activity by
7.8-fold and 9.2-fold, respectively, in the absence of TCDD
Figure 1. Cis-elements in the intergenic region of mouse aB-crystallin and HspB2 gene and the potential AhR binding site (‘‘XRE-like’’
motif). Some binding sites for transcriptional factors are located in the indicated elements. There is a potential AhR binding site indicated as ‘‘XRE-
like’’ motif identified by bioinformatics. The core sequence (2323/2329) is underlined. GR, Glucocorticoid Receptor; HSF, Heat Shock Factor; RAR,
Retinoic Acid Receptor; RXR, Retinoid X Receptor; Maf, Macrophage Activating Factor.
doi:10.1371/journal.pone.0017904.g001
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of aB-crystallin promoter activity.
It has been reported that AhR activity differs among cell types
[24,25,26]. Thus we examined the AhR/ARNT regulation on aB-
crystallin promoter in seven different cell lines and used the cyp1a1
promoter, a target gene positively regulated by AhR/ARNT
[10,11], as a positive control. Interestingly, the results differed with
cell type (Fig. 6). In HeLa, NIH3T3 and COS-7 cells, AhR/ARNT
increased aB-crystallin promoter activity by 11.3-fold, 5.5-fold and
3.3-fold, respectively, in a TCDD-independent manner; in CV-1,
C2C12 and Hepa-1 cells, AhR/ARNT did not stimulate aB-crystallin
promoter activity; in aTN4 lens cells, AhR/ARNT increased aB-
crystallin promoter activity by 2.1-fold, and this stimulation was
increased to 4.2-fold by the addition of TCDD. As expected, AhR/
ARNT increased cyp1a1 promoter activity in all the cell types tested;
AhR/ARNT stimulation was appreciably increased by the addition
of TCDD in HeLa, COS-7 and Hepa-1 cells, moderately enhanced
in C2C12 cells, and slightly elevated if at all in NIH3T3 and CV-1
cells (Fig. 6). We conclude from these experiments that AhR/
ARNT can positively regulate aB-crystallin promoter activity TCDD
independently or dependently depending upon the cell type.
AhR Binds the XRE-like Motif in the aB-Crystallin
59-Regulatory Region
Gel shift and ChIP assays were performed to test whether AhR
can bind the XRE-like motif that we identified in the aB-crystallin
enhancer. In gel shift experiments using aTN4 cell nuclear
extracts and a 22 bp oligonucleotide containing the XRE-like
motif (indicated in Fig. 7C as aB-wt), a weak but specific band
representing the AhR/XRE-like motif complex was detected in
untreated aTN4 cells (Fig. 7B, lane 2). AhR/ARNT transfection
and TCDD addition increased the band intensity individually
(Fig. 7B, lane 3, 4) and additively when combined (Fig. 7B, lane 5).
Western blot also revealed separate and additive effects of AhR/
ARNT transfection and TCDD addition on nuclear AhR
accumulation (Fig. 7A). The band was competed by a 25-fold
molar excess of non-radioactive probe (Fig. 7B, lane 6), and
became smeared or decreased in intensity by the addition of anti-
AhR antibody to the reaction mixture (Fig. 7B, lane 8). The anti-
ARNT antibody did not affect the bands (Fig. 7B, lane 9). In
further gel shift experiment using HeLa cells (data not shown), the
specific band of complex was more intense using nuclear extracts
from cells transfected with the AhR/ARNT vector than from cells
transfected with the control vector (pcDNA3.1). Not as in the
experiments with the aTN4 cells, TCDD did not increase the
band intensity in the experiments with HeLa cells. These results
are consistent with our functional tests using aTN4 and HeLa cells
indicating that AhR regulates the aB-crystallin promoter (see Fig. 6).
We next examined the binding specificity of AhR to the XRE-
like motif (CATGCGA) by mutating this site (aB-wt) to an XRE-I
(CACGCAA) sequence (aB-mu1+), an XRE-II (CATGCC-
CAATCTT) sequence (aB-mu2+), or a sequence lacking an
Figure 2. aB-crystallin is decreased in AhR
2/2 mice. A. Cornea, retina, lens, heart, and skeletal muscle were isolated from adult AhR
2/2 and
AhR
+/+ mice and tissue proteins extracted. Primary fibroblasts from skeletal muscle were cultured and cell proteins extracted. aB-crystallin was
analyzed by Western immunoblotting. b-actin was detected as an internal control. (n=4, *, p,0.05). B. aB-crystallin mRNA levels were determined by
real time-PCR using total RNA extracted from whole eyes, heart and limb skeletal muscle. GAPDH mRNA levels were determined as an internal control
(n=2, **, p,0.01).
doi:10.1371/journal.pone.0017904.g002
Arylhydrocarbon Receptor Target to ab-Crystallin
PLoS ONE | www.plosone.org 3 April 2011 | Volume 6 | Issue 4 | e17904XRE site (aB-mu2; CAAAAAA) (Fig. 7C). Protein-oligonucleo-
tide complex formation was more intense with the aB-mu1+
sequence (Fig. 7C, lane 2) and weaker with the aB-mu2+ sequence
(lane 3) than with the aB-wt sequence (Fig. 7C, lane 1). No discrete
band was produced with the aB-mu2 (Fig. 7C, lane 4). These
results are consistent with DNA sequence-specific binding of AhR
to XRE-related motifs.
A previous report indicated that in vitro translated AhR/ARNT
does not bind to the XRE-II motif, suggesting that in vivo binding
requires additional proteins or posttranslational modification(s)
[12]. Therefore, we examined the capacity of in vitro translated
AhR/ARNT to bind the XRE-like motif (Fig. 7D). The AhR/
ARNT generated by a rabbit reticulocyte expression system bound
the XRE-I motif in the presence of TCDD (100 nM) (Fig. 7D,
lane 2) but did not bind the XRE-like motif in the gel shift
experiments (Fig. 7D, lane 3,4). Either binding of the in vitro
generated AhR/ARNT to the XRE-like and/or XRE-II sequenc-
es required modification that was not performed by the system, or
other factor(s) are needed for binding to occur.
The binding abilities of AhR to the XRE-like, XRE-I and
XRE-II motifs were compared by competition experiments using
HeLa cells (Fig. 8). A 10, 25, and 100-fold molar excess of XRE-I
motif gradually eliminated the binding of AhR to the XRE-like
motif (Fig. 8, Lane 1–4); by contrast, appreciable complex of AhR
to the XRE-I sequence remained even at a 100-fold molar excess
of the XRE-like sequence (Fig. 8, lanes 5–8), consistent with
stronger AhR binding to XRE-I than to the XRE-like sequence.
There was no competition for AhR binding between the XRE-like
and the XRE-II motifs (Fig. 8, lanes 9–16).
We next tested the in vivo interaction of AhR with the XRE-like
motif in aTN4 cells by ChIP analysis (Fig. 9). DNA isolated from
anti-AhR antibody precipitated complexes was amplified by PCR
and real time-PCR using a pair of primers that could amplify the
sequence containing the XRE-like motif (Fig. 9A). The predicted
band of 250 bp was detected in untransfected aTN4 cells
indicating complex formation in the untreated cells. In AhR/
ARNT transfected aTN4 cells, a much stronger band was
detected and TCDD addition further increased the band intensity
(Fig. 9B, C). The results of these ChIP experiments are consistent
with our functional transfection and gel mobility shift experiments
suggesting an in vivo role for AhR in aB-crystallin gene expression.
The XRE-like Motif is Necessary for Basal aB-Crystallin
Promoter Activity and Maximal AhR/ARNT-Inducible aB-
Crystallin Promoter Activity
We tested the functional importance of the XRE-like motif for
aB-crystallin promoter activity. The XRE-like motif in the reporter
construct was mutated either to an XRE-I sequence or to a non-
XRE sequence identical to those used for the binding assays above
(Fig. 10). Mutating the XRE-like motif to a non-XRE sequence
reduced basal promoter activity by 85% and reduced maximal
AhR/ARNT-induced promoter activity by 86% relative to the
Figure 3. The effects of AhR knock-down and over-expression on aB-crystallin expression. A. 80 pmol of siRNA targeting AhR mRNA
(si-AhR) or non-targeting siRNA (si-ctrl) were transfected into aTN4 cells and total cell proteins were extracted 60 h later. Expression of AhR and aB-
crystallin were determined by Western immunoblotting. B. 0.1, 0.25, 0.5 and 1 mg pcDNA3.1/B6AhR and pcDNA/ARNT were co-transfected into aTN4
cells and total cell proteins were extracted 24 h later. AhR, ARNT and aB-crystallin were detected by Western immunoblotting. b-actin was detected
as an internal control. ( *, p,0.05; **, p,0.01; ***, p,0.001).
doi:10.1371/journal.pone.0017904.g003
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like motif is necessary and important for basal aB-crystallin
promoter activity and maximal AhR/ARNT-inducibility.
Discussion
The present report suggests that aB-crystallin is a target gene for
the transcription factor, AhR. aB-crystallin protein expression was
reduced in the eyes (lens and cornea), heart, skeletal muscle and
primarily cultured fibroblasts in AhR
2/2 mice. The AhR
2/2
mice had no detectable aB-crystallin in the retina, where both aB-
crystallin and AhR are known to be prevalent in vertebrates and
invertebrates [22,23,27,28,29,30]. Although no connection is
known between aB-crystallin and retinal function, it is noteworthy
that disruption of the Drosophila AhR ortholog, Spineless, disables
color vision in this species [29].
The present data indicate that aB-crystallin protein and mRNA
levels are decreased in the eyes of AhR
2/2 mice; however,
histological examination of these eyes revealed no obvious
morphological abnormality in the eyes of either adult or 19 day-
old postnatal pups of AhR
2/2 mice (data not shown). In this
connection, it is noteworthy and consistent with reports that
although AhR protein [31,32] and aB-crystallin mRNA [33] are
highly expressed in the lens of 12–15 day-old mouse embryos, the
lenses of neither AhR null mice [34] nor aB-crystallin [35] null
mice appear abnormal. Thus, the precise developmental roles of
AhR and aB-crystallin in the lens, as well as in other tissues,
require additional investigation.
Our strongest evidence that AhR regulates aB-crystallin gene
expression comes from the combination of transfection experi-
ments that tested for promoter function and gel mobility shift
assays that tested for direct binding to DNA. AhR stimulated the
aB-crystallin promoter in transfected cells and formed a complex
with the XRE-like site in the aB-crystallin enhancer. Mutation of
this site reduced both promoter activation and AhR binding.
Mutation of the XRE-like site also lowered the basal promoter
activity of the aB-crystallin gene as well as the ability of the
promoter to be activated by AhR. It is noteworthy, however, that
AhR did not stimulate aB-crystallin promoter activity in all types of
transfected cells. Positive results were obtained in HeLa, NIH3T3,
COS-7 and aTN4 cells, but not in C2C12, CV-1 or Hepa-1 cells.
The reason for this cell type-dependency is not known, but
suggests that specific interaction with one or more factors is
essential. It is also intriguing that although the XRE-like site is
necessary for both basal promoter activity and AhR-stimulation of
promoter activity, it binds AhR weakly. One possibility for the
weak binding in our tests is that additional proteins that were not
present in the gel shift reaction mixture are required for maximal
complex formation. The inability of in vitro translated AhR/ARNT
to form a complex with the XRE-like site is consistent with this
possibility. Further studies on AhR binding to the aB-crystallin
promoter both in vivo and in vitro using physiological levels of
nuclear proteins are warranted.
Our in vitro functional and gel shift experiments, as well as ChIP
experiments, indicate that AhR can stimulate aB-crystallin promoter
activity inthe absenceofTCDD. A caveatis that TCDD increase of
AhR stimulation of the aB-crystallin promoter depends on cell type
(i.e. aTN4 cells). AhR can also regulate other gene expression, for
example TGFb1, independently of TCDD [36]. Indeed, the
expression of a large number of genes not affected by TCDD in
different tissues was altered in AhR
2/2 mice [17,18]. It is unknown
whether these represent direct or indirect effects of AhR. The genes
altered in the AhR null mice are enriched for classic XRE sites, and
it is likely that various transcription factors collaborate with AhR in
Figure 4. The effects of AhR/ARNT on aB-crystallin promoter activity. A. Structure of the pFLHspB2aBRL dual reporter plasmid used for
reporter assays. B. AhR/ARNT up-regulates aB-crystallin but not HspB2 promoter activity. 50 ng pcDNA3.1/B6AhR and 50 ng pcDNA/ARNT were
co-transfected into HeLa cells with 100 ng pFLHspB2aBRL and 10 ng b-gal control vector. Luciferase activities were determined 48 h later. Data are
presented as the ratio of firefly luciferase activity to b-gal activity (Relative Luciferase Unit, RLU) to indicate HspB2 promoter activity, or the ratio of
Renilla luciferase activity to b-gal activity to indicate aB-crystallin promoter activity. The results are presented as mean values; S.D. values were derived
from three independent experiments.
doi:10.1371/journal.pone.0017904.g004
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in wild type mice [18]. It remains possible, of course, that a yet
unknown endogenous ligand substitutes for TCDD in certain cases
or under specific conditions. FICZ (6-formylindolo[3,2-b]carbazole)
and/or other tryptophan derivatives are candidate endogenous
ligands for AhR [37].
Finally it is noteworthy that in preliminary tests (data not shown)
AhR/ARNT increased the activity of a truncated aB-crystallin
promoter lacking the XRE-like site (2257 to +43) up to 24% of
the AhR/ARNT-induced wild type promoter. Since the identified
XRE-like site is the only sequence resembling a classical XRE
sequence in the 59 flanking region of the aB-crystallin gene, it is
possible that AhR stimulated aB-crystallin activity of the truncated
promoter by binding another sequence via one or more scaffolding
proteins. Alternatively, AhR/ARNT may have activated another
gene that in turn stimulated activity of the truncated promoter.
Further studies are necessary to resolve the multiple interactions
involved in aB-crystallin gene expression.
In summary, whatever the mechanism, our data suggest that
AhR/ARNT participates in the regulation of the aB-crystallin gene.
Apart from its intrinsic interest with respect to the complex
mechanism of aB-crystallin gene expresssion [38,39], AhR regulation
of the aB-crystallin gene is biologically logical: both aB-crystallin and
AhR function in mediating cellular stress responses [39,40].
Materials and Methods
Chemicals and Antibodies
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) was purchased
from Cambridge Isotope Laboratories, Inc. Anti-AhR antibody
(RPT9) and anti-ARNT antibody (2B10) were purchased from
Abcam Inc. Anti-aB-crystallin antibody was purchased from
Stressgen. Anti-b-actin antibody was purchased from Sigma. Anti-
Histone H3 antibody was purchased from Abcam Inc.
Cell Lines-HeLa (CCL-2) cells, Hepa1-6 (CRL-1830) cells, C2C12
(CRL-1772) cells, NIH3T3(CRL-1658) cells, CV-1 (CCL-70) and
COS-7 (CRL-1651) cells were purchased from ATCC and
maintained in Dulbecco’s modified Eagle’s medium (DMEM)
with 10% fetal bovine serum. aTN4 cells were maintained as
previously described [8].
Plasmids and Site-Directed Mutagenesis
The plasmids encoding mouse AhR protein (pcDNA3.1/
B6AhR and pcDNA3.1/D2AHR) and the cyp1a1 reporter
plasmid (P1646luc3) were kindly provided by Dr. Alvaro Puga
(University of Cincinnati College of Medicine). The plasmid
encoding mouse ARNT protein (pcDNA/ARNT) was kindly
provided by Dr. Oliver Hankinson (University of California, Los
Angeles, California). The dual-directional reporter plasmid
Figure 5. AhR/ARNT up-regulates aB-crystallin promoter activity independently of TCDD. A. AhR and ARNT dose-dependently up-regulate
aB-crystallin promoter activity. Increasing doses of pcDNA3.1/B6AhR and pcDNA/ARNT were co-transfected with fixed amounts of pFLHspB2aBRL and
b-gal control vector into HeLa cells. After 24 h the cells were treated for another 24 h with TCDD (10 nM) or DMSO (0.01%) and then assayed for
luciferase activities. B. Effects of TCDD on aB-crystallin promotor activity. HeLa cells transfected with pcDNA3.1/B6AhR and pcDNA/ARNT or control
vector were treated with progressive concentrations of TCDD as indicated. After 24 h the cells were assayed for luciferase activities. C. Effects of high
ligand-affinity AhR (B6/AhR) and low ligand-affinity AhR (D2/AhR) on aB-crystallin promoter activity. HeLa cells were co-transfected with pcDNA3.1/
B6AhR or pcDNA3.1/D2AhR with pFLHspB2aBRL and b-gal control vector. After 24 h the cells were treated with TCDD (10 nM) or DMSO (0.01%) for
another 24 h and then assayed for luciferase activities. The fold change was recorded by determining luciferase activity in AhR/ARNT transfected and/
or TCDD-treated cells relative to that in the pcDNA3.1 transfected and DMSO-treated cells. The means and S.D. values were derived from three
independent experiments.
doi:10.1371/journal.pone.0017904.g005
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luciferase) is described elsewhere [3]. Site-directed mutagenesis
was performed with the QuikChange Site-Directed Mutagenesis
kit (Stratagene). The primers containing mutated site were
synthesized by Integrated DNA Technologies Inc as follows:
aB-mu1+:5 9-TCA ATT CCC CTG GCA CGC AAG ACT
GGA GAG (in which CATGCGARCACGCAA); aB-mu1-: 59-
GGC TCA ATT CCC CTG GCA AAA AA G ACT GGA GAG
GAG GAG GGG (in which CATGCGARCAAAAAA).
siRNA Experiments-Small interfering RNA (siRNA) targeting
mouse AhR (si-AhR) and non-targeting siRNA (si-ctrl) were
synthesized by Dharmacon. 80 pmol of si-AhR and si-ctrl were
transfected into aTN4 cells using Lipofectamine2000 (Invitrogen).
Total cell protein was extracted by RIPA buffer (Pierce) after 60 h
and AhR, aB-crystallin and b-actin protein levels were estimated
by immunoblotting.
Transfection and Reporter Gene/Luciferase Assay
Cells were grown in 24-well plates to 40–50% confluence and
co-transfected with pcDNA3.1/B6AhR, pcDNA/ARNT or
pcDNA3.1 (vector) and reporter plasmids using Fugene6 (Roche
Applied Science). pCMVb-gal (Clontech) or pRL-CMV (Pro-
mega) was co-transfected to normalize for transfection efficiency.
TCDD (10 nM) or DMSO (0.01%) was added into the culture
medium 24 h after transfection and the cells were incubated for
another 24 h. Luciferase activities were determined in 20 mlo f
cell lysate by a Dual Luciferase Assay kit (Promega) on a
GloMax
TM 96 microplate luminometer (Promega). Relative
luciferase activities (Relative Luciferase Unit, RLU) were
expressed as the ratio of the promoter activities generated by
the reporter plasmid to that of the control plasmid. Fold change
was recorded as the ratio of RLU from experimental group versus
control group.
Figure 6. AhR/ARNT up-regulates aB-crystallin promoter activity in a cell-type dependent manner. pFLHspB2aBRL or the cyp1a1 reporter
plasmid was co-transfected with pcDNA3.1/B6AhR, pcDNA/ARNT and b-gal control vector into the specified cells as indicated and the cells were
cultured for 24 h. Cells were incubated with TCDD (10 nM) or DMSO (0.01%) for another 24 h before luciferase activities were determined. The fold
change was recorded by determining luciferase activity in AhR/ARNT transfected and/or TCDD-treated cells relative to that in the pcDNA3.1
transfected and DMSO-treated cells. The means and S.D. values were derived from three independent experiments. Three types of AhR/ARNT and
TCDD induced-aB-crystallin promoter responses were detected, depending on the cell type, as indicated under the boxed results. AhR/ARNT
increased Cyp1a1 promoter activity in all the cell types tested and showed variable, cell-type dependent additional stimulation in the presence of
TCDD.
doi:10.1371/journal.pone.0017904.g006
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PLoS ONE | www.plosone.org 7 April 2011 | Volume 6 | Issue 4 | e17904Figure 7. AhR binds to the XRE-like motif in the aB-crystallin enhancer. A. Nuclear AhR levels in aTN4 cells. aTN4 cells were transfected with
pcDNA3.1/B6AhR and pcDNA/ARNT or pcDNA3.1 for 24 h, treated with or without 10 nM TCDD for 2 h, and then nuclear extracts were prepared. AhR
protein levels were tested by western immunoblotting. Histone 3 was immunoblotted as an internal control. B. The 2336/2315 fragment of the
mouse aB-crystallin gene containing the XRE-like motif was synthesized and labeled with
32P. Nuclear extracts were prepared from aTN4 cells
transfected with pcDNA3.1/B6AhR and pcDNA/ARNT, treated with 10 nM TCDD or DMSO (0.01%) for 2 h. Gel shift was performed as described under
‘‘ Materials and Methods’’. Arrows indicate the specific protein-DNA band. The band was induced by AhR/ARNT and increased by the combination of
AhR/ARNT and 10 nM TCDD. The band was competed by 25-fold excess unlabeled probe or AhR antibody, but not by ARNT antibody. C. Gel shifts
testing the binding of AhR to the XRE-like motif or to its mutant sequences. Equal amounts of nuclear extract from aTN4 cells transfected with
pcDNA3.1/B6AhR and pcDNA/ARNT, treated with TCDD were incubated with a
32P-labeled XRE-like sequence or with mutated
32P-labeled XRE-I, XRE-
II or non-XRE sequences, as indicated; the protein-DNA complexes were analyzed by gel shift. Arrows indicate the specific bands. D. In vitro translated
AhR/ARNT did not bind to the XRE-like motif. Mouse AhR and ARNT were synthesized in a rabbit reticulocyte lysate in the presence of 100 nM TCDD
or vehicle for 90 min. The binding capability of the in vitro synthesized AhR/ARNT to the XRE-like, XRE-I and XRE-II motifs were tested by gel shift.
doi:10.1371/journal.pone.0017904.g007
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Culture
Hindlimb skeletal muscles were removed from age matched adult
AhR
2/2 and AhR
+/+ mice (kindly provided by Dr. Frank Gonzalez;
National Cancer Institute). This study was carried out in strict
accordance with the recommendations in the Guide for the Care and
Use of Laboratory Animals, National Research Council, Institute of
Laboratory Animal Resources, 1996. The Animal Study Protocol
( 0 6 - 5 6 0 )w a sa p p r o v e db yt h eA n i m a lC a r ea n dU s eC o m m i t t e eo f
the National Eye Institute, National Institutes of Health. The mice
were euthanized by exposure to CO2 gas following the American
VeterinaryMedical Association Guidelines on Euthanasia, June 2007
and all efforts were made to minimize suffering. After removing
fascia, fat, and connective tissue, the muscles were washed three times
in PBS, minced into small pieces and digested with 0.2% trypsin-
EDTA (Invitrogen) at 37uC for 30 min before centrifugation at
2,000 rpm for 5 min. The pellets were resuspended in DMEM and
incubated at 37uCa n d5 %C O 2 for 30 min. Non-adherent cells were
removed and the adherent cells were washed with PBS to discard
remaining myogenic cells. The fibroblasts were cultured in DMEM
medium with 10% fetal bovine serum for several generations.
Protein and mRNA Preparation
Mice were euthanized by CO2 and the cornea, lens, retina, heart,
and limb skeletal muscles were surgically excised. Tissue pellet were
resuspended in RIPA buffer (Pierce) supplemented with protease and
phosphatase inhibitor cocktail (Pierce),homogenized for 30 sec on ice
and centrifuged at 14,0006g for 15 min at 4uC. Aliquots of the
supernatant fractions werestored at 280uC. For protein preparation,
cells were washed by PBS, scrapped and collected. Total protein was
extracted at 4uC in RIPA buffer supplemented with protease and
phosphatase inhibitor cocktail. The cell lysates were centrifuged and
aliquots of the supernatant fractions stored at 280uC. Cell nuclear
extracts were prepared using the nuclear extract kit (Active Motif)
following the instructions of the manufacturer. For mRNA
preparations, the specified tissues were snap frozen in liquid nitrogen
a n ds t o r e da t280uC. mRNA extractions were performed using a
Qiagen RNeasy Plus Mini Kit (Qiagen).
Western blot
Protein lysates were quantified using a BCA Protein Assay kit
(Pierce). Equal amounts of protein were subjected to 4–12% Bis-
Tris SDS-PAGE (Invitrogen) and transferred electrophoretically
onto a nitrocellulose membrane. The membrane was blocked with
5% fat-free milk/PBST, sequentially incubated with primary
antibody overnight at 4uC and secondary antibodies for 1 h at
room temperature, and autoradiographed by the ECL detection
kit (Pierce).
In Vitro Transcription and Translation
1 mg pcDNA3.1/B6AhR and 1 mgp c D N A / A R N Tw e r e
separately transcribed and translated in vitro using a rabbit
reticulocyte lysate expression kit (Promega) following the
manufacturer’s instruction. The reaction mixtures were com-
bined and incubated with 100 nM TCDD or DMSO (0.01%) for
1 h at 30uC. 5 ml of each lysate was used for gel shift
experiments.
Gel Shift
10 mg nuclear protein or 5 ml in vitro-translated protein were
mixed with 1 ml poly (dI-dC) in 10 ml buffer (25 mM Hepes,
60 mM KCl, 1 mM DTT, 1% glycerol, 2% CHAPs, 4 mM
spermidine) on ice for 30 min. 1 ml
32P-labeled oligonucleotides
was incubated in the reaction mixture for 30 min at room
temperature. For competition experiments, a 25- to 100-fold
molar excess of unlabeled oligonucleotides was incubated with the
nuclear extract for 30 min on ice prior to addition of the
32P-labeled probe. Supershift tests were conducted by incubation
of 1 mg AhR or ARNT antibody with nuclear extract prior to the
addition of the
32P-labeled probe. Protein-DNA complexes were
analyzed in a 6% polyacrylamide DNA retardation gel (Invitro-
gen) using 0.56 Tris borate EDTA (TBE) buffer. The gel was
dried and subjected to autoradiography.
Chromatin Immunoprecipitation (ChIP) Assays
Cells were rinsed with PBS and crosslinked with 1%
formaldehyde for 10 min at room temperature; the reaction was
Figure 8. Competitions between XRE-like motif and XRE-I motif or XRE-II motif for AhR binding. The XRE-like, XRE-I and XRE-II motif
oligonuccleotides were labels with
32P and incubated with nuclear extracts from pcDNA3.1/B6AhR and pcDNA/ARNT transfected, TCDD (10 nM)-
treated HeLa cells. 10-, 25-, and 100-fold molar excess of unlabeled oligonucleotides were pre-incubated with the nuclear extract prior to incubation
with the labeled oligonucleotides. The bands indicated by arrows in the gel shift experiments represent the specific complexes of AhR.
doi:10.1371/journal.pone.0017904.g008
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collected in ice-cold PBS and centrifuged at 3,000 rpm for 5 min
at 4uC. The cell pellets were resuspended in 1 ml lysis buffer
(50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 5 mM MgCl, 1 mM
EGTA, 0.5% TritonX-100, protease inhibitor cocktail freshly
added) and incubated on ice for 10 min. The cell lysates were
centrifuged at 5,000 rpm for 5 min and nuclei were resuspended
in 300 ml nuclear lysis buffer (1% SDS, 50 mM Tris-HCl,
pH 8.0, 10 mM EDTA, protease inhibitor cocktail freshly
added). The suspensions were sonicated to produce DNA
fragments of 300–900 bp, centrifuged at 13,000 rpm for
10 min, and the supernatant fractions removed. The supernatant
fractions were pre-blocked with protein G sepharose beads in
nine volumes of dilution buffer (lysis buffer) for 1 h at 4uC and
centrifuged; subsequently, the supernatant fractions were incu-
bated with 2 ug goat anti-AhR antibody overnight at 4uCw i t h
gentle rotation. The immunocomplexes were precipitated by
protein G sepharose beads, pelleted and washed sequentially with
buffer I (0.1% SDS, 1% TritonX-100, 2 mM EDTA, 20 mM
Tris, pH 8, 150 mM NaCl), buffer II (0.1% SDS, 1% TritonX-
100, 2 mM EDTA, 20 mM Tris, ph 8, 500 mM NaCl), buffer III
( 0.25 M LiCl, 1% NP-40, 1% NaDOC, 1 mM EDTA, 10 mM
Tris, pH 8), and three times with TE buffer. The samples were
boiled, centrifuged and the supernatant fractions collected. After
dilution with three volumes of water, 2 ml sample were subjected
to 50 PCR cycles or processed by real time PCR on a 7900HT
Fast Real-Time PCR System (Applied Biosystem) using SYBRH
Green PCR Master Mix kit (Applied Biosystem). The primers for
amplifying the 2265 to 2466 fragment of the aB-crystallin
enhancer containing the XRE-like motif were: 59-AGC TCA
TTC CAG TCA GA and 59-GCT AGG ATG GAG CCT GGA
AT.
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